Veraxa Biotech Holding AG (VRXAW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 12Aug 17Aug 20Aug 25Aug 28Sep 4Sep 10Sep 17

Key dataSep 17, 2026

Open$0.07

From 52W high−75.10%

Volume0.00

Market cap$1.80M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 17, 2026

Open

$0.07

From 52W high

−75.10%

Volume

0.00

Market cap

$1.80M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

43.3

MomentumView details →

1D Return

+1.86%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+1.86%

YTD Return

—

1Y Return

—

RSI (14)

43.3

vs 50D SMA

−32.67%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

VERAXA Biotech announced a collaboration with Ardigen to support its BiTAC pipeline of T cell engagers and antibody drug conjugates.69d ago

Xlife Sciences AG disclosed a 16.3% stake in Veraxa Biotech Holding AG via a 13D/G filing.97d ago

Similar companies

Decoy Therapeutics Inc.DCOY Protagenic Therapeutics, Inc.PTIX Virax Biolabs Group LimitedVRAX Avenue Therapeutics, Inc.ATXI Clearside Biomedical, Inc.CLSD Artelo Biosciences, Inc.ARTL Find similar companies →

Latest newsMore news →

VERAXA Biotech announced a collaboration with Ardigen to support its BiTAC pipeline of T cell engagers and antibody drug conjugates.69d ago Xlife Sciences AG disclosed a 16.3% stake in Veraxa Biotech Holding AG via a 13D/G filing.97d ago VERAXA Biotech completed a business combination with Voyager Acquisition Corp. and will begin trading on NASDAQ under ticker VRXA on June 11, 2026.102d ago